Clinical Trials Logo
  1. Home
  2. Influenza Infection
  3. NCT01008020

Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection

Influenza Infection Clinical Trial

Official title:
A Randomized Controlled Study on the Effects of Tea Catechin Consumption on the Prevention of Influenza Infection in Healthy Adults

Clinical Trial Summary

The Purpose of this study is to evaluate the effects of 5 months catechin consumption on the prevention of influenza infection.

Clinical Trial Description

Catechins are the major components of tea flavonoids and are reported to possess physiological activities such as antiviral effects. Recent experimental studies have revealed that tea catechin extracts prevent influenza infection, but few studies have been conducted on the clinical effects of tea catechin consumption on the prophylaxis of influenza infection. Based on these backgrounds, we designed a prospective randomized controlled study to evaluate the effects of 5 months tea catechin consumption on the prophylaxis of influenza infection. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01008020
Study type Interventional
Source University of Shizuoka
Contact
Status Completed
Phase N/A
Start date November 2009
Completion date October 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT00603811 - Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults Phase 1
Completed NCT03784885 - A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult Phase 2
Recruiting NCT05436444 - Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model Phase 1
Completed NCT01201902 - A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine Phase 3
Completed NCT00559975 - Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine Phase 1
Terminated NCT00647465 - Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer Phase 3
Recruiting NCT01225770 - Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers Phase 3
Completed NCT00239213 - Catechin Gargling for Influenza Infection N/A
Terminated NCT04933968 - Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant Phase 1/Phase 2
Not yet recruiting NCT04298060 - DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19) Phase 2
Completed NCT01049490 - Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination Device N/A
Completed NCT02367885 - Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants Phase 1/Phase 2
Completed NCT02313155 - Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults Phase 1/Phase 2
Completed NCT00812448 - Catechin Containing Mask for the Prevention of Influenza Infection N/A
Active, not recruiting NCT05818124 - Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019) Phase 1
Terminated NCT01160237 - Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM Phase 3
Completed NCT03814720 - Dose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults Phase 1